Marktprognose für Schnelltests in Nordamerika bis 2030 – Regionale Analyse – nach Typ (Schnelltests auf Antigene, Schnelltests auf Antikörper und andere), Produkt (rezeptfreie Schnelltests und professionelle Schnelltests), Technologie (Lateralflusstest, Festphasentest, Agglutination, Immunospot-Test und auf zellulären Komponenten basierend), Anwendung (Blutzuckertests, Tests auf Infektionskrankheiten, Schwangerschaft und Fruchtbarkeit, kardiometabolische Tests und andere) und Endbenutzer (Krankenhäuser und Kliniken, häusliche Pflege, Diagnosezentren und andere)
Steigende Prävalenz genetischer und infektiöser Krankheiten treibt nordamerikanischen Markt für Schnelltestkits an
Ein Bericht von MJH Life Sciences (USA) aus dem Jahr 2022 schätzt, dass jedes Jahr weltweit 300.000 Neugeborene mit Sichelzellenanämie geboren werden. Laut CDC ist 1 von 500 Afroamerikanern von Sichelzellenanämie betroffen. Der jüngste Welt-Malaria-Bericht (WMR) 2022 der Weltgesundheitsorganisation (WHO) gibt an, dass im Jahr 2021 weltweit fast 247 Millionen neue Malariafälle gemeldet wurden, verglichen mit 245 Millionen Fällen im Jahr 2020. Der gleichen Quelle zufolge betrug die Zahl der Todesfälle durch Malaria im Jahr 2021 619.000.
Sickle SCAN ist ein Schnelltest zur Identifizierung von Sichelzellenanämie mit hoher Sensitivität und Spezifität. Schnelle Diagnosetests (RDTs) helfen bei der Diagnose von Malaria, indem sie das Vorhandensein von Malariaparasiten im menschlichen Blut nachweisen. Wo der Zugang zu hochwertigen Mikroskopiediensten eingeschränkt ist, werden radiologische Diagnosetechniken als Alternative zur klinischen oder mikroskopbasierten Diagnose eingesetzt. Die COVID-19-Pandemie hatte erhebliche Auswirkungen auf den Markt für Schnelltestkits. Fast alle Diagnosetests verwendeten Echtzeit-PCR zum Testen von Personen, die Symptome einer SARS-CoV-2-Infektion zeigten. Schnelltestkits sind nahezu allgegenwärtig, robust und zuverlässig. In den meisten molekularbiologischen Laboren werden Schnelltestverfahren eingesetzt, bei denen bestimmte DNA-Abschnitte zur Genotypisierung, Klonierung und Analyse einzelner Nukleotidvariationen amplifiziert werden. Die zunehmende Häufigkeit genetischer und infektiöser Erkrankungen treibt daher das Wachstum des Marktes für Schnelltestkits voran.
Marktübersicht für Schnelltestkits in Nordamerika
Die schnelle Einführung von Gensynthese- und Bearbeitungstools wie CRISPR und PCR in Forschung und Therapie erfordert Tests, die für eine schnelle Quantifizierung, Veränderung und Beobachtung hilfreich sind. Die USA, die erhebliche Mittel von öffentlichen und privaten Organisationen anstreben, werden voraussichtlich erheblich in fortschrittliche Forschungsmethoden investieren und voraussichtlich eine führende Position auf dem Markt für Schnelltestkits einnehmen. Zwischen den SARS-CoV-2 Delta- und Omicron-dominierten Perioden der Pandemie kam es zu einem raschen Anstieg der Verwendung von Heimtests. Laut CDC wurden im April 2023 in den USA mehr als 70 Millionen Testkits verschickt.
Umsatz und Prognose des nordamerikanischen Marktes für Schnelltestkits bis 2030 (Mio. USD)
Segmentierung des nordamerikanischen Marktes für Schnelltestkits
Der nordamerikanische Markt für Schnelltestkits ist nach Typ, Produkt, Technologie, Anwendung, Endbenutzer und Land segmentiert. Nach Typ ist der nordamerikanische Markt für Schnelltestkits in schnelle Antigentests, schnelle Antikörpertests und andere unterteilt. Das Segment der schnellen Antigentests hatte 2022 den größten Marktanteil.
In Bezug auf das Produkt ist der nordamerikanische Markt für Schnelltestkits in rezeptfreie Schnelltestkits und professionelle Schnelltestkits unterteilt. Das Segment der rezeptfreien Schnelltestkits hatte 2022 einen größeren Marktanteil.
Nach Technologie ist der nordamerikanische Markt für Schnelltestkits in Lateral-Flow-Assay, Festphasen-, Agglutinations-, Immunospot-Assay und zellkomponentenbasierte Tests segmentiert. Das Segment Lateral-Flow-Assays hatte 2022 den größten Marktanteil.
Basierend auf der Anwendung ist der nordamerikanische Markt für Schnelltestkits in Blutzuckertests, Tests auf Infektionskrankheiten, Schwangerschaft und Fruchtbarkeit, kardiometabolische Tests und andere unterteilt. Das Segment Blutzuckertests hatte 2022 den größten Marktanteil.
In Bezug auf den Endverbraucher ist der nordamerikanische Markt für Schnelltestkits in Krankenhäuser und Kliniken, häusliche Pflege, Diagnosezentren und andere unterteilt. Das Segment Krankenhäuser und Kliniken hatte 2022 den größten Marktanteil.
Basierend auf dem Land ist der nordamerikanische Markt für Schnelltestkits in die USA, Kanada und Mexiko unterteilt. Die USA dominierten 2022 den nordamerikanischen Marktanteil für Schnelltestkits.
F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, SD Biosensor Inc, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA und Beckman Coulter Inc sind einige der führenden Akteure auf dem nordamerikanischen Markt für Schnelltestkits.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Rapid Test Kits Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Genetic and Infectious Diseases
4.1.2 Strategic Initiatives by Manufacturers
4.2 Market Restraints
4.2.1 Uncertainties Related to Accuracy of Results
4.3 Market Opportunities
4.3.1 Increasing Preference for PCR Techniques
4.4 Future Trends
4.4.1 Innovations in Rapid Antigen Tests
4.5 Impact Analysis
5. Rapid Test Kits Market - North America Market Analysis
5.1 Overview
5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
6. North America Rapid Test Kits Market Analysis - by Type
6.1 Overview
6.2 Rapid Antigen Testing
6.2.1 Overview
6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Rapid Antibody Testing
6.3.1 Overview
6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7. North America Rapid Test Kits Market Analysis - by Product
7.1 Overview
7.2 Over-the-Counter Rapid Testing Kit
7.2.1 Overview
7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Professional Rapid Testing Kit
7.3.1 Overview
7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Rapid Test Kits Market Analysis - by Technology
8.1 Overview
8.2 Lateral Flow Assay
8.2.1 Overview
8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Solid Phase
8.3.1 Overview
8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Agglutination
8.4.1 Overview
8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Immunospot Assay
8.5.1 Overview
8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Cellular-Component Based
8.6.1 Overview
8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Rapid Test Kits Market Analysis - by Application
9.1 Overview
9.2 Blood Glucose Testing
9.2.1 Overview
9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Infectious Disease Testing
9.3.1 Overview
9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
9.4.1 Overview
9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Pregnancy and Fertility
9.5.1 Overview
9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Rapid Test Kits Market Analysis - by End User
10.1 Overview
10.2 Hospital and Clinics
10.2.1 Overview
10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Home-Care
10.4.1 Overview
10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11. North America Rapid Test Kits Market - Country Analysis
11.1 North America: Rapid Test Kits Market
11.1.1 North America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
11.1.1.1 United States
11.1.1.1.1 Overview
11.1.1.2 United States: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.1 United States: Rapid Test Kits Market Breakdown, by Type
11.1.1.2.2 United States: Rapid Test Kits Market Breakdown, by Product
11.1.1.2.3 United States: Rapid Test Kits Market Breakdown, by Technology
11.1.1.2.4 United States: Rapid Test Kits Market Breakdown, by Application
11.1.1.2.4.1 United States: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.2.5 United States: Rapid Test Kits Market Breakdown, by End User
11.1.1.3 Canada
11.1.1.3.1 Overview
11.1.1.4 Canada: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.1 Canada: Rapid Test Kits Market Breakdown, by Type
11.1.1.4.2 Canada: Rapid Test Kits Market Breakdown, by Product
11.1.1.4.3 Canada: Rapid Test Kits Market Breakdown, by Technology
11.1.1.4.4 Canada: Rapid Test Kits Market Breakdown, by Application
11.1.1.4.4.1 Canada: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.4.5 Canada: Rapid Test Kits Market Breakdown, by End User
11.1.1.5 Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.1 Overview
11.1.1.6 Mexico
11.1.1.6.1 Mexico: Rapid Test Kits Market Breakdown, by Type
11.1.1.6.2 Mexico: Rapid Test Kits Market Breakdown, by Product
11.1.1.6.3 Mexico: Rapid Test Kits Market Breakdown, by Technology
11.1.1.6.4 Mexico: Rapid Test Kits Market Breakdown, by Application
11.1.1.6.4.1 Mexico: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.6.5 Mexico: Rapid Test Kits Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Rapid Test Kit Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Becton Dickinson and Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ARKRAY Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Fujirebio Europe NV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 bioMerieux SA
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Cepheid
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Meril Life Sciences Pvt Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 QIAGEN NV
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 OraSure Technologies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Guangzhou Wondfo Biotech Co Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Denka Co Ltd
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Abbott Laboratories
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Trinity Biotech Plc
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 SD Biosensor Inc
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Bio-Rad Laboratories Inc
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 Hologic Inc
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 DiaSorin SpA
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 Beckman Coulter Inc
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
14. Appendix
14.1 About The Insight Partners
List of Tables
Table 1. Rapid Test Kits Market Segmentation
Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 4. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 5. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 6. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 7. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 8. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 10. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 11. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 12. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 13. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 14. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 16. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 17. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 18. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 20. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
Table 22. Recent Organic Growth Strategies in the Rapid Test Kit Market
List of Figures
Figure 1. Rapid Test Kits Market Segmentation, By Country
Figure 2. Rapid Test Kits Market: Key Industry Dynamics
Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)
Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)
Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)
Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)
Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)
Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. North America: Rapid Test Kits Market, by Key Country - Revenue (2022) (US$ Million)
Figure 30. North America: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 31. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 34. Growth Strategies in the Rapid Test Kit Market
1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. ARKRAY Inc
4. Fujirebio Europe NV
5. bioMerieux SA
6. Cepheid
7. Meril Life Sciences Pvt Ltd
8. QIAGEN NV
9. OraSure Technologies Inc
10. Guangzhou Wondfo Biotech Co Ltd
11. Denka Co Ltd
12. Abbott Laboratories
13. Trinity Biotech Plc
14. SD Biosensor Inc
15. Bio-Rad Laboratories Inc
16. Hologic Inc
17. DiaSorin SpA
18. Beckman Coulter Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America rapid test kit market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America rapid test kit market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America rapid test kit market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.